Rockwell Automation (ROK) FY Conference May 08, 2025 02:15 PM ET Speaker0 Well, good afternoon, everyone, and, welcome back to day four of Oppenheimer's twentieth Annual Industrial Growth Conference. We're very happy to have, back to the conference, Rockwell Automation, Ajana Zehlner, head of IR and market strategy. Known each other many years, and I really appreciate you making the time right after earnings to come talk to us. So, Ajana, let's Speaker1 Would have missed it. Speaker0 Let's get into it. You ...

Compass Therapeutics (CMPX) 2025 Conference May 08, 2025 01:30 PM ET Speaker0 so we're gonna go ahead and get started on time. Again, welcome to the second day of the Citizens Life Science Conference. It's my pleasure to introduce the next presenting company which is Compass Therapeutics. Presenting for the company or having our discussion is Doctor. Tom Schutz, CEO of Compass. Welcome Tom, really appreciate your time. Speaker1 Thanks, Ren. Thanks for inviting us. Speaker0 So, you know, people in the audien ...

Rapport Therapeutics (RAPP) 2025 Conference May 08, 2025 01:30 PM ET Speaker0 Go ahead and get started here. So thank you again for joining us this afternoon at the Citizens Life Science Conference. Excited to be joined next by Rapport Therapeutics. Rapport is a company focused on developing precision neuroscience, therapeutics. Lead program, RAP219 is being developed for focal epilepsy and, we also think there's a pipeline and product potential here as well, as well as a really exciting platform that the t ...

Enpro (NPO) FY Conference May 08, 2025 01:30 PM ET Speaker0 Thank you. Good afternoon, everybody. I am Ian Zaffino. I am the equity research analyst covering EnPro. Thank you everybody for joining our industrial conference today. With me from the company will be Joe Broderick and also James Chantille. Joe is the CFO and James is the vice president of investor relations. So with that, guys, thanks for for joining us, and we appreciate you you being here. Speaker1 Pleasure, Ian. Thank you. Speaker0 So I figur ...

Senti Biosciences (SNTI) 2025 Conference May 08, 2025 01:00 PM ET Speaker0 Are you ready to kick it off? Yeah. Whenever you guys wanna do. Speaker1 Okay. Welcome back to the Citizens Life Science Conference. My name is Silvan Turca, and I'm a senior analyst covering precision medicines. And now it's my pleasure to introduce Sandi Biosciences. Presenting will be Tim Liu, CEO and cofounder, and Jay Cross, CFO. Thank you so much for coming and joining us today. Speaker0 Well, thanks a lot, Silvan. Appreciate t ...

Contango Ore (CTGO) Update / Briefing May 08, 2025 01:00 PM ET Speaker0 Good evening, depending on where in the world you're signing in from. Certainly, a lot of time zones on today's call, so I do appreciate you joining us. I'm on the TangoWorks talk about the recent publishing of the technical report summary on the Johnson Track project with some pretty attractive economics. So I've got on today, CEO, Rick Van Nuneheiser and CFO, Mike Clark, gentlemen. How are you today? Speaker1 Doing well. Romeo, I'm in ...

Modine Manufacturing Company (MOD) FY Conference May 08, 2025 12:45 PM ET Speaker0 Well, good afternoon, everyone, and welcome back to day four of Oppenheimer's twentieth Annual Industrial Growth Conference. I'm Noah Kaye, Managing Director and Equity Research here at OpCo. We're very happy to welcome back the management team of Modine to our conference. Neil Brinker, president CEO, Mick Lucarelli, CFO, Kathy Powers, VP of IR. Thank you all for being here, and looking forward to a great discussion. Well, go ...

Esperion Therapeutics (ESPR) 2025 Conference May 08, 2025 12:30 PM ET Speaker0 I guess take a step back and Primary. I guess take a step back and go go through the data that went into those new labels. Can you just walk us through the clear outcome study and the findings there? Speaker1 So the clear outcome study was a 14,000 patient outcome study which measured MACE four, MACE three in a variety of endpoints in both a, in a non statin population in both a primary and secondary prevention patient population ...

Pharvaris (PHVS) Conference May 08, 2025 12:30 PM ET Speaker0 Try and keep running out schedule here. Good afternoon, everybody. Thanks for joining us for a session with Barbarus. My name is John Wallovan, senior analyst here at Citizens Life Sciences at our twenty twenty five conference. We have Pong Lu and Wim Sovian. Speaker1 Good. Good enough. Speaker0 Head of head of, medical and head of commercial. So it's a perfect time to to jump in that hereditary angioedema. Cat's out of the bag, but tell us what ...

Limbach (LMB) FY Conference May 08, 2025 12:00 PM ET Speaker0 Great. Thank you, everybody. Mike McCann, President and CEO of Limbach Holdings. Joining me on this call today will be Jamie Brooks, EVP and CFO. She'll be available for Q and A. So look forward to getting into the discussion today, a little bit about Limbach Holdings. We reported at the end of the day, Monday, and we'll be talking about our growth strategy and market opportunity. So the first thing, a lot of times we are classified as E and C co ...